In 2021, it was estimated that about 23% of adults living in Las Vegas, NV had arthritis. Osteoarthritis (OA), the most common form of arthritis, affects millions of people worldwide. OA symptoms can ...
Total revenues of $167.1 million Net product sales of $132.4 million for EXPAREL, $25.8 million for ZILRETTA, and $5.0 million for iovera° Net income of $9.0 million, or $0.19 per share (basic and ...
On Tuesday, Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch nerves to manage chronic low back pain. The ioveraº system is a ...
Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system compared to radiofrequency ablation (RFA) for chronic low back pain (CLBP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results